Limnos

Omeprazole, the active ingredient in Limnos, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is employed in the management of acid‑related disorders such as gastro‑esophageal reflux disease and peptic ulcer disease.

GNH USA supplies Limnos as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Our distribution network ensures timely delivery and regulatory compliance across EU and other markets.

Omeprazole, a proton pump inhibitor, is used to manage conditions associated with excess gastric acid secretion.

- Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Helicobacter pylori eradication regimens: enhances the effectiveness of antibiotic combinations. - Prevention of NSAID‑induced gastric ulcers: protects the gastric mucosa in patients receiving non‑steroidal anti‑inflammatory drugs.

Omeprazole may cause adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: feeling of stomach discomfort. - Abdominal pain: cramp‑like discomfort in the abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Acute interstitial nephritis: renal inflammation with possible impaired kidney function. - Hypomagnesemia: low serum magnesium leading to muscle cramps or arrhythmias. - Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Before initiating therapy, consider the following precautions.

- Assess renal and hepatic function: adjust use if impairment is present. - Review concomitant medications: avoid known contraindicated drugs. - Monitor for signs of infection: prolonged acid suppression may increase risk. - Use with caution in pregnancy: limited data, weigh benefits versus risks. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Omeprazole can affect the pharmacokinetics of several drugs. Review patient medication lists carefully.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - High‑dose methotrexate: increased toxicity risk.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR. - Diazepam: elevated serum concentrations. - Digoxin: possible increase in drug levels.